Indegene to host Premji Invest for analyst meeting on Sep 11

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Indegene hosts Premji Invest for a one-on-one meeting
  • Session scheduled for September 11, 2026, in Bengaluru
  • Disclosure made under SEBI LODR Regulations 2015
  • No unpublished price-sensitive information to be shared
powered bylight_fuzz_icon
50396334

*this image is generated using AI for illustrative purposes only.

Indegene will host an in-person investor and analyst meeting with Premji Invest on Friday, September 11, 2026. The one-on-one session is scheduled to take place in Bengaluru, Karnataka.

The company issued the intimation on September 8, 2026, pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Srishti Ramesh Kaushik, Company Secretary and Compliance Officer, confirmed the schedule.

Meeting Details

Date Counterparty Mode Nature Location
September 11, 2026 Premji Invest In Person 1 x 1 Meeting Bengaluru

The company stated that no unpublished price-sensitive information will be shared during the interaction. The schedule remains subject to change. Further details are available on the company website.

Historical Stock Returns for Indegene

1 Day5 Days1 Month6 Months1 Year5 Years
+0.17%-3.63%+1.69%+27.76%+3.72%0.0%

What strategic rationale might drive Premji Invest to seek a dedicated in-person meeting with Indegene rather than relying on standard quarterly disclosures?

Could this engagement signal potential changes in Indegene's ownership structure or board composition in the near future?

How might market participants interpret this high-profile investor interaction regarding Indegene's valuation and growth trajectory for FY27?

Indegene gets US court preliminary approval for USD 4.72 million class action settlement

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • U.S. court preliminarily approves class action settlement for Indegene Inc.
  • Maximum settlement fund capped at approximately USD 4.72 million
  • Eligible claimants to receive USD 250 per approved claim
  • Final approval hearing scheduled for January 12, 2027
  • Settlement follows a claims-made structure with no pre-funding required
powered bylight_fuzz_icon
49729052

*this image is generated using AI for illustrative purposes only.

Indegene has received preliminary approval from a U.S. court for a class action settlement involving its wholly-owned subsidiary, Indegene Inc. The settlement framework caps the fund at approximately USD 4.72 million.

Settlement details and timeline

The U.S. District Court, District of New Jersey, issued the order on August 27, 2026. The court approved the notice process and appointed Analytics as the Settlement Administrator. Notices to class members will be issued on or before September 10, 2026.

Parameter Details
Company Indegene
Subsidiary involved Indegene Inc.
Settlement amount Up to USD 4.72 million
Claim payment USD 250 per eligible claim
Claims deadline December 9, 2026
Final hearing January 12, 2027

Structure of the payout

The settlement operates on a claims-made basis. Actual payments depend on the number of valid claims received and approved. Each eligible approved claim will receive USD 250. There is no requirement to deposit or pre-fund the entire maximum settlement amount. Any funds not required to satisfy approved claims will revert to the defendants.

What this means

Preliminary approval allows the settlement terms to be communicated to class members. It does not constitute final approval. The settlement remains subject to the completion of the court-approved notice and claims process. The final approval hearing is scheduled for January 12, 2027, where the court will make a conclusive determination on validity and fairness.

This development follows previous disclosures by Indegene Limited regarding the litigation under the Telephone Consumer Protection Act, 1991. The preliminary order does not alter the previously disclosed settlement framework.

Historical Stock Returns for Indegene

1 Day5 Days1 Month6 Months1 Year5 Years
+0.17%-3.63%+1.69%+27.76%+3.72%0.0%

How might the final settlement payout compare to the $4.72 million cap based on historical claim rates for similar TCPA class actions?

What impact could this resolution have on Indegene's operational compliance protocols regarding automated communications in the U.S.?

Will the preliminary approval influence investor sentiment or stock volatility leading up to the January 2027 final hearing?

More News on Indegene

Must Read Next

Stocks

USFDA issues two observations at Dr. Reddy's Mexico facility 28 mins ago
Strides Pharma Science receives three USFDA remarks at Alathur facility 28 mins ago
1 Year Returns:+3.72%